Fate Therapeutics, Inc.FATENASDAQ
Loading
Year-over-year total asset growth rate
Latest
-7.20%
↓ 186% vs avg
Percentile
P36
Within normal range
Streak
1 qtr
Consecutive growthDecelerating
Average
8.37%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -7.20% |
| Q3 2025 | -7.52% |
| Q2 2025 | -6.78% |
| Q1 2025 | -9.54% |
| Q4 2024 | -10.97% |
| Q3 2024 | -6.40% |
| Q2 2024 | -7.21% |
| Q1 2024 | 12.58% |
| Q4 2023 | -6.91% |
| Q3 2023 | -7.01% |
| Q2 2023 | -7.23% |
| Q1 2023 | -10.66% |
| Q4 2022 | -5.84% |
| Q3 2022 | -7.15% |
| Q2 2022 | -5.98% |
| Q1 2022 | -6.84% |
| Q4 2021 | -6.41% |
| Q3 2021 | -3.06% |
| Q2 2021 | -2.90% |
| Q1 2021 | 68.04% |
| Q4 2020 | -0.64% |
| Q3 2020 | -4.15% |
| Q2 2020 | 103.05% |
| Q1 2020 | 6.49% |
| Q4 2019 | -11.15% |
| Q3 2019 | 70.21% |
| Q2 2019 | -9.50% |
| Q1 2019 | 3.68% |
| Q4 2018 | -3.15% |
| Q3 2018 | 164.51% |
| Q2 2018 | -10.99% |
| Q1 2018 | -11.28% |
| Q4 2017 | 44.88% |
| Q3 2017 | -1.73% |
| Q2 2017 | -13.33% |
| Q1 2017 | -10.23% |
| Q4 2016 | 92.81% |
| Q3 2016 | 0.24% |
| Q2 2016 | -16.23% |
| Q1 2016 | -13.62% |